Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps
- Wall Street open lower on weak China factory data
- Pre-Open Stock Movers 09/01: (TRVN) (KTOS) (ALKS) Higher; (ADEP) (DLTR) (GPRO) Lower (more...)
- General Motors (GM) U.S. Sales Fell Less than Expected in August
- Apple (AAPL) Said Planning to Produce Original Video Content (NFLX)
- Deutsche Bank Upgrades American Airlines (AAL), Delta (DAL), and Copa (CPA) to Buy
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westport (WPRT) halted with news pending
- Fuel Systems Solutions (FSYS) halted with news pending
- AstraZeneca (AZN) Enters Brodalumab Licensing Agreement with Valeant (VRX)
Create E-mail Alert Related CategoriesFDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!